Quantitative IC₅₀ Analysis of Puromycin-Induced Cytotoxicity in NIH/3T3 Cells Using a Multi-Well Array Impedance...

Area of Science:

• Biomedical Engineering
• Pharmacology
• Cell Biology

Background:

• Electrical cell-substrate impedance sensing (ECIS) biosensors are used in various fields, but interpreting impedance signals for biological significance is underexplored.
• Most ECIS studies focus on monitoring cellular behavior via impedance changes, with less emphasis on quantitative biological interpretation.

Purpose of the Study:

• To employ a multi-well array impedance biosensor for half-maximal inhibitory concentration (IC50) analysis.
• To evaluate the drug toxicity and efficacy of puromycin using impedance biosensing.
• To determine the IC50 value of puromycin for NIH/3T3 fibroblasts.

Main Methods:

• Utilized a multi-well array impedance biosensor for real-time monitoring.
• Exposed NIH/3T3 fibroblasts to varying concentrations of puromycin.
• Performed capacitance-based impedance analysis to assess cell viability and determine IC50 values.

Main Results:

• The IC50 value of puromycin for NIH/3T3 cells was determined to be 3.96 µM.
• Demonstrated the capability of the impedance biosensor for quantitative drug toxicity evaluation.
• Confirmed puromycin's inhibitory effect on protein synthesis in fibroblasts.

Conclusions:

• The multi-well array impedance biosensor provides a rapid and quantitative method for drug toxicity evaluation.
• This impedance biosensor platform is valuable for drug screening and biocompatibility assessment.
• Capacitance-based impedance analysis effectively determines drug efficacy metrics like IC50.